6.
Gordon S, Pluddemann A
. Macrophage Clearance of Apoptotic Cells: A Critical Assessment. Front Immunol. 2018; 9:127.
PMC: 5797608.
DOI: 10.3389/fimmu.2018.00127.
View
7.
Patterson A, Watson A
. Deciphering the Complex Signaling Systems That Regulate Intestinal Epithelial Cell Death Processes and Shedding. Front Immunol. 2017; 8:841.
PMC: 5513916.
DOI: 10.3389/fimmu.2017.00841.
View
8.
Livak K, Schmittgen T
. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8.
DOI: 10.1006/meth.2001.1262.
View
9.
Hamaya Y, Yoshida K, Takai T, Ikuma M, Hishida A, Kanaoka S
. Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer. Br J Cancer. 2010; 102(5):916-21.
PMC: 2833255.
DOI: 10.1038/sj.bjc.6605564.
View
10.
Daulagala A, Bridges M, Kourtidis A
. E-cadherin Beyond Structure: A Signaling Hub in Colon Homeostasis and Disease. Int J Mol Sci. 2019; 20(11).
PMC: 6600153.
DOI: 10.3390/ijms20112756.
View
11.
Beaulieu J, Herring E
. Toward a Stool mRNA-Based Assay for Detection of Colorectal Cancer Lesions. Gastroenterology. 2019; 158(3):793.
DOI: 10.1053/j.gastro.2019.10.033.
View
12.
Herring E, Kanaoka S, Tremblay E, Beaulieu J
. Droplet digital PCR for quantification of in a stool mRNA assay for the detection of colorectal cancers. World J Gastroenterol. 2017; 23(16):2891-2898.
PMC: 5413784.
DOI: 10.3748/wjg.v23.i16.2891.
View
13.
Wang X, Yang F, Xu G, Zhong S
. The roles of IL-6, IL-8 and IL-10 gene polymorphisms in gastric cancer: A meta-analysis. Cytokine. 2018; 111:230-236.
DOI: 10.1016/j.cyto.2018.08.024.
View
14.
Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z
. Single-cell and spatial analysis reveal interaction of FAP fibroblasts and SPP1 macrophages in colorectal cancer. Nat Commun. 2022; 13(1):1742.
PMC: 8976074.
DOI: 10.1038/s41467-022-29366-6.
View
15.
Krzystek-Korpacka M, Diakowska D, Kapturkiewicz B, Bebenek M, Gamian A
. Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance. Cancer Lett. 2013; 337(1):107-14.
DOI: 10.1016/j.canlet.2013.05.033.
View
16.
Beaulieu J, Herring E, Kanaoka S, Tremblay E
. Use of integrin alpha 6 transcripts in a stool mRNA assay for the detection of colorectal cancers at curable stages. Oncotarget. 2016; 7(12):14684-92.
PMC: 4924744.
DOI: 10.18632/oncotarget.7407.
View
17.
Oladipo O, Conlon S, OGrady A, Purcell C, Wilson C, Maxwell P
. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. Br J Cancer. 2011; 104(3):480-7.
PMC: 3049559.
DOI: 10.1038/sj.bjc.6606055.
View
18.
Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I
. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263.
DOI: 10.3322/caac.21834.
View
19.
Grotzer M, Patti R, Geoerger B, Eggert A, CHOU T, Phillips P
. Biological stability of RNA isolated from RNAlater-treated brain tumor and neuroblastoma xenografts. Med Pediatr Oncol. 2000; 34(6):438-42.
DOI: 10.1002/(sici)1096-911x(200006)34:6<438::aid-mpo12>3.0.co;2-q.
View
20.
Lin J, Perdue L, Henrikson N, Bean S, Blasi P
. Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021; 325(19):1978-1998.
DOI: 10.1001/jama.2021.4417.
View